Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Risk of colonic diverticular rebleeding according to endoscopic appearance.

Kawanishi K, Kato J, Kakimoto T, Hara T, Yoshida T, Ida Y, Maekita T, Iguchi M, Kitano M.

Endosc Int Open. 2018 Jan;6(1):E36-E42. doi: 10.1055/s-0043-122494. Epub 2018 Jan 12.

2.

The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients.

Taki S, Tamai H, Ida Y, Shingaki N, Kawashima A, Shimizu R, Moribata K, Maekita T, Iguchi M, Kato J, Nakao T, Kitano M.

Gut Liver. 2018 Jan 15;12(1):86-93. doi: 10.5009/gnl17048.

3.

Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.

Nuta J, Shingaki N, Ida Y, Shimizu R, Hayami S, Ueno M, Fukatsu K, Itonaga M, Yoshida T, Maeda Y, Moribata K, Deguchi H, Maekita T, Iguchi M, Kato J, Yamaue H, Tamai H.

Ultrasound Med Biol. 2017 Sep;43(9):1829-1836. doi: 10.1016/j.ultrasmedbio.2017.04.023. Epub 2017 Jun 16.

PMID:
28625558
4.

Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus.

Tamai H, Ida Y, Kawashima A, Shingaki N, Shimizu R, Moribata K, Nasu T, Maekita T, Iguchi M, Kato J, Nakao T, Kitano M.

Gut Liver. 2017 Jul 15;11(4):551-558. doi: 10.5009/gnl16525.

5.

Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir.

Tamai H, Ida Y, Shingaki N, Shimizu R, Fukatsu K, Itonaga M, Yoshida T, Maeda Y, Moribata K, Maekita T, Iguchi M, Kato J, Kitano M.

Hepat Res Treat. 2017;2017:2093847. doi: 10.1155/2017/2093847. Epub 2017 Apr 11.

6.

Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis.

Muhammad JS, Nanjo S, Ando T, Yamashita S, Maekita T, Ushijima T, Tabuchi Y, Sugiyama T.

Int J Cancer. 2017 May 15;140(10):2272-2283. doi: 10.1002/ijc.30657. Epub 2017 Mar 14.

7.

Rapid On-Site Evaluation by Endosonographers during Endoscopic Ultrasonography-Guided Fine-Needle Aspiration for Diagnosis of Gastrointestinal Stromal Tumors.

Tamura T, Yamashita Y, Ueda K, Kawaji Y, Itonaga M, Murata SI, Yamamoto K, Yoshida T, Maeda H, Maekita T, Iguchi M, Tamai H, Ichinose M, Kato J.

Clin Endosc. 2017 Jul;50(4):372-378. doi: 10.5946/ce.2016.083. Epub 2017 Jan 20.

8.

High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study.

Maeda M, Nakajima T, Oda I, Shimazu T, Yamamichi N, Maekita T, Asada K, Yokoi C, Ando T, Yoshida T, Nanjo S, Fujishiro M, Gotoda T, Ichinose M, Ushijima T.

Gut. 2017 Sep;66(9):1721-1723. doi: 10.1136/gutjnl-2016-313387. Epub 2016 Dec 21. No abstract available.

9.

Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.

Shagdarsuren B, Tamai H, Shingaki N, Mori Y, Maeshima S, Nuta J, Maeda Y, Moribata K, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

J Ultrasound Med. 2016 Jul;35(7):1383-91. doi: 10.7863/ultra.15.08042. Epub 2016 May 20.

PMID:
27208196
10.

Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.

Iguchi M, Kato J, Yoshida T, Yamamoto Y, Nakachi K, Fukatsu K, Mori Y, Maeda Y, Moribata K, Shingaki N, Niwa T, Deguchi H, Inoue I, Maekita T, Tamai H, Ichinose M.

Int J Cancer. 2016 Sep 1;139(5):1150-6. doi: 10.1002/ijc.30145. Epub 2016 May 5.

11.

The Wire-Grasping Method as a New Technique for Forceps Biopsy of Biliary Strictures: A Prospective Randomized Controlled Study of Effectiveness.

Yamashita Y, Ueda K, Kawaji Y, Tamura T, Itonaga M, Yoshida T, Maeda H, Magari H, Maekita T, Iguchi M, Tamai H, Ichinose M, Kato J.

Gut Liver. 2016 Jul 15;10(4):642-8. doi: 10.5009/gnl15231.

12.

Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.

Nuta J, Tamai H, Mori Y, Shingaki N, Maeshima S, Shimizu R, Maeda Y, Moribata K, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

J Ultrasound Med. 2016 Feb;35(2):359-71. doi: 10.7863/ultra.15.04067. Epub 2016 Jan 18.

PMID:
26782163
13.

Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication.

Moribata K, Iguchi JK, Nakachi K, Maeda Y, Shingaki N, Niwa T, Deguchi H, Inoue I, Maekita T, Tamai H, Ichinose M.

Dig Endosc. 2015 Dec 1. doi: 10.1111/den.12581. [Epub ahead of print]

PMID:
26623565
14.

Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus.

Tamai H, Shingaki N, Mori Y, Moribata K, Kawashima A, Maeda Y, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Gut Liver. 2016 Jul 16;10(4):617-23. doi: 10.5009/gnl15193.

15.

The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.

Shimizu R, Tamai H, Mori Y, Shingaki N, Maeshima S, Nuta J, Maeda Y, Moribata K, Muraki Y, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Hepatol Int. 2016 Mar;10(2):328-39. doi: 10.1007/s12072-015-9678-1. Epub 2015 Nov 3.

PMID:
26530813
16.

Video capsule endoscopy as the initial examination for overt obscure gastrointestinal bleeding can efficiently identify patients who require double-balloon enteroscopy.

Maeda Y, Moribata K, Deguchi H, Inoue I, Maekita T, Iguchi M, Tamai H, Kato J, Ichinose M.

BMC Gastroenterol. 2015 Oct 14;15:132. doi: 10.1186/s12876-015-0362-7.

17.

Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.

Mori G, Nakajima T, Asada K, Shimazu T, Yamamichi N, Maekita T, Yokoi C, Fujishiro M, Gotoda T, Ichinose M, Ushijima T, Oda I.

Gastric Cancer. 2016 Jul;19(3):911-8. doi: 10.1007/s10120-015-0544-6. Epub 2015 Sep 29.

PMID:
26420267
18.

Hypointense hepatocellular carcinomas on apparent diffusion coefficient mapping: Pathological features and metastatic recurrence after hepatectomy.

Mori Y, Tamai H, Shingaki N, Hayami S, Ueno M, Maeda Y, Moribata K, Deguchi H, Niwa T, Inoue I, Maekita T, Iguchi M, Kato J, Terada M, Yamaue H, Ichinose M.

Hepatol Res. 2016 Jun;46(7):634-41. doi: 10.1111/hepr.12598. Epub 2015 Nov 5.

PMID:
26407147
19.

Argon plasma coagulation is effective for prevention of recurrent esophageal varices after endoscopic injection sclerotherapy: Single-center case-control study.

Deguchi H, Kato J, Maeda Y, Moribata K, Shingaki N, Niwa T, Inoue I, Maekita T, Iguchi M, Tamai H, Ichinose M.

Dig Endosc. 2016 Jan;28(1):42-9. doi: 10.1111/den.12538. Epub 2015 Oct 26.

PMID:
26295791
20.

Japanese apricot improves symptoms of gastrointestinal dysmotility associated with gastroesophageal reflux disease.

Maekita T, Kato J, Enomoto S, Yoshida T, Utsunomiya H, Hayashi H, Hanamitsu T, Inoue I, Maeda Y, Moribata K, Muraki Y, Shingaki N, Deguchi H, Ueda K, Iguchi M, Tamai H, Ichinose M.

World J Gastroenterol. 2015 Jul 14;21(26):8170-7. doi: 10.3748/wjg.v21.i26.8170.

21.

Contrast-Enhanced Endoscopic Ultrasonography for Pancreatic Tumors.

Yamashita Y, Kato J, Ueda K, Nakamura Y, Kawaji Y, Abe H, Nuta J, Tamura T, Itonaga M, Yoshida T, Maeda H, Maekita T, Iguchi M, Tamai H, Ichinose M.

Biomed Res Int. 2015;2015:491782. doi: 10.1155/2015/491782. Epub 2015 May 18.

22.

Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis.

Tamai H, Mori Y, Shingaki N, Shimizu R, Nuta J, Moribata K, Maeda Y, Muraki Y, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Takifuji K, Yamaue H, Ichinose M.

Hepatol Int. 2015 Jan;9(1):67-75. doi: 10.1007/s12072-014-9586-9. Epub 2014 Nov 1.

PMID:
25788381
23.

Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.

Nakachi K, Tamai H, Mori Y, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Cancer Imaging. 2014 Apr 22;14:7. doi: 10.1186/1470-7330-14-7.

24.

Migration of gastrostomy site: rare complication of percutaneous endoscopic gastrostomy.

Maekita T, Nakazawa K, Kato J.

Dig Endosc. 2015 Mar;27(3):398-9. doi: 10.1111/den.12411. Epub 2015 Jan 16. No abstract available.

PMID:
25491388
25.

Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study.

Asada K, Nakajima T, Shimazu T, Yamamichi N, Maekita T, Yokoi C, Oda I, Ando T, Yoshida T, Nanjo S, Fujishiro M, Gotoda T, Ichinose M, Ushijima T.

Gut. 2015 Mar;64(3):388-96. doi: 10.1136/gutjnl-2014-307094. Epub 2014 Jun 2.

26.

Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks.

Tamai H, Shimizu R, Shingaki N, Mori Y, Maeshima S, Nuta J, Maeda Y, Moribata K, Muraki Y, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Hepat Res Treat. 2014;2014:748935. doi: 10.1155/2014/748935. Epub 2014 Sep 28.

27.

Prediction of a null response to pegylated interferon α-2b plus ribavirin in patients with high viral load genotype 1b hepatitis C.

Wada Y, Tamai H, Kawashima A, Shingaki N, Mori Y, Kawaguchi M, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Gut Liver. 2014 Jul;8(4):421-7. doi: 10.5009/gnl.2014.8.4.421. Epub 2014 Apr 23.

28.

Contrast-enhanced endoscopic ultrasonography can predict a higher malignant potential of gastrointestinal stromal tumors by visualizing large newly formed vessels.

Yamashita Y, Kato J, Ueda K, Nakamura Y, Abe H, Tamura T, Itonaga M, Yoshida T, Maeda H, Moribata K, Niwa T, Maekita T, Iguchi M, Tamai H, Ichinose M.

J Clin Ultrasound. 2015 Feb;43(2):89-97. doi: 10.1002/jcu.22195. Epub 2014 Jul 16.

PMID:
25043900
29.

Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.

Shingaki N, Tamai H, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Mol Clin Oncol. 2013 Nov;1(6):977-981. Epub 2013 Sep 17.

30.

Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms.

Inoue I, Kato J, Tamai H, Iguchi M, Maekita T, Yoshimura N, Ichinose M.

World J Gastroenterol. 2014 Feb 14;20(6):1485-92. doi: 10.3748/wjg.v20.i6.1485. Review.

31.

Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation.

Mori Y, Tamai H, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Terada M, Ichinose M.

Hepatol Res. 2015 Jan;45(1):75-87. doi: 10.1111/hepr.12311. Epub 2014 Apr 2.

PMID:
24533527
32.

Common Bile Duct Dilatation With Stones Indicates Requirement for Early Drainage in Patients With or Without Cholangitis.

Yamashita Y, Ueda K, Abe H, Tamura T, Itonaga M, Yoshida T, Maeda H, Maekita T, Iguchi M, Tamai H, Ichinose M, Kato J.

Gastroenterology Res. 2013 Dec;6(6):219-226. Epub 2014 Jan 15.

33.

Low-dose pegylated interferon-α2a plus ribavirin therapy for elderly and/or cirrhotic patients with HCV genotype-1b and high viral load.

Tamai H, Mori Y, Shingaki N, Kawashima A, Tsukuda H, Higashi K, Moribata K, Kawaguchi M, Ueda K, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Antivir Ther. 2014;19(1):107-15. doi: 10.3851/IMP2696. Epub 2013 Oct 25.

PMID:
24162072
34.

Usefulness of continuous suction mouthpiece during esophagogastroduodenoscopy: A single-center, prospective, randomized study.

Maekita T, Kato J, Nakatani Y, Enomoto S, Takano E, Tsuji M, Nakaya T, Moribata K, Muraki Y, Shingaki N, Niwa T, Deguchi H, Ueda K, Inoue I, Iguchi M, Tamai H, Ichinose M.

World J Gastrointest Endosc. 2013 Oct 16;5(10):508-13. doi: 10.4253/wjge.v5.i10.508.

35.

Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.

Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M.

Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3.

36.

Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer.

Yamashita Y, Ueda K, Itonaga M, Yoshida T, Maeda H, Maekita T, Iguchi M, Tamai H, Ichinose M, Kato J.

Pancreas. 2013 Aug;42(6):990-5. doi: 10.1097/MPA.0b013e31827fe94c.

PMID:
23851433
37.

Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks.

Wada Y, Tamai H, Uno A, Kawashima A, Shingaki N, Mori Y, Moribata K, Miyata K, Higashi K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Hepatol Res. 2014 Feb;44(2):179-86. doi: 10.1111/hepr.12101. Epub 2013 Mar 27.

PMID:
23531032
38.

Usefulness of a continuous suction mouthpiece during percutaneous endoscopic gastrostomy: a single-center, prospective, randomized study.

Maekita T, Kato J, Nakatani Y, Enomoto S, Kayama T, Tsuji M, Nakaya T, Muraki Y, Deguchi H, Ueda K, Inoue I, Iguchi M, Tamai H, Ichinose M.

Dig Endosc. 2013 Sep;25(5):496-501. doi: 10.1111/den.12017. Epub 2012 Dec 26.

PMID:
23368904
39.

Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation.

Moribata K, Tamai H, Shingaki N, Mori Y, Shiraki T, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Ichinose M.

World J Hepatol. 2012 Dec 27;4(12):374-81. doi: 10.4254/wjg.v4.i12.374.

40.

Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis.

Yoshida T, Kato J, Maekita T, Yamashita S, Enomoto S, Ando T, Niwa T, Deguchi H, Ueda K, Inoue I, Iguchi M, Tamai H, Ushijima T, Ichinose M.

Gastric Cancer. 2013 Oct;16(4):488-97. doi: 10.1007/s10120-012-0230-x. Epub 2013 Jan 6.

PMID:
23292007
41.

Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia.

Inoue I, Kato J, Yoshimura N, Maeda Y, Moribata K, Shingaki N, Deguchi H, Enomoto S, Maekita T, Ueda K, Iguchi M, Tamai H, Fujishiro M, Yamamichi N, Takeshita T, Ichinose M.

Mol Clin Oncol. 2013 Jan;1(1):75-82. Epub 2012 Sep 11.

42.

Usefulness of contrast-enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms: a single-center prospective study.

Yamashita Y, Ueda K, Itonaga M, Yoshida T, Maeda H, Maekita T, Iguchi M, Tamai H, Ichinose M, Kato J.

J Ultrasound Med. 2013 Jan;32(1):61-8.

PMID:
23269711
43.

Low-dose pegylated interferon-alpha-2a monotherapy in elderly and/or cirrhotic patients infected with hepatitis C virus genotype-2 or genotype-1 low level infection.

Tamai H, Moribata K, Mori Y, Shingaki N, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.

Hepatol Res. 2013 Jul;43(7):702-8. doi: 10.1111/hepr.12024. Epub 2012 Dec 17.

PMID:
23252609
44.

Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers.

Kim JG, Takeshima H, Niwa T, Rehnberg E, Shigematsu Y, Yoda Y, Yamashita S, Kushima R, Maekita T, Ichinose M, Katai H, Park WS, Hong YS, Park CH, Ushijima T.

Cancer Lett. 2013 Mar 1;330(1):33-40. doi: 10.1016/j.canlet.2012.11.022. Epub 2012 Nov 27.

45.

Relationship between vomiting reflex during esophagogastroduodenoscopy and dyspepsia symptoms.

Enomoto S, Watanabe M, Yoshida T, Mukoubayashi C, Moribata K, Muraki Y, Shingaki N, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Tamai H, Kato J, Fujishiro M, Oka M, Mohara O, Ichinose M.

Dig Endosc. 2012 Sep;24(5):325-30. doi: 10.1111/j.1443-1661.2012.01241.x. Epub 2012 Mar 15.

PMID:
22925284
46.

A case of chronic pancreatitis in which endoscopic ultrasonography was effective in the diagnosis of a pseudoaneurysm.

Fukatsu K, Ueda K, Maeda H, Yamashita Y, Itonaga M, Mori Y, Moribata K, Shingaki N, Deguchi H, Enomoto S, Inoue I, Maekita T, Iguchi M, Tamai H, Kato J, Ichinose M.

World J Gastrointest Endosc. 2012 Jul 16;4(7):335-8. doi: 10.4253/wjge.v4.i7.335.

47.

Diazepam during endoscopic submucosal dissection of gastric epithelial neoplasias.

Muraki Y, Enomoto S, Iguchi M, Niwa T, Maekita T, Yoshida T, Moribata K, Shingaki N, Deguchi H, Ueda K, Inoue I, Tamai H, Kato J, Fujishiro M, Ichinose M.

World J Gastrointest Endosc. 2012 Mar 16;4(3):80-6. doi: 10.4253/wjge.v4.i3.80.

48.

Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.

Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C, Deguchi H, Enomoto S, Ueda K, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Tekeshita T, Mohara O, Ushijima T, Ichinose M.

Int J Cancer. 2012 Dec 1;131(11):2632-42. doi: 10.1002/ijc.27514. Epub 2012 Mar 28.

49.

Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection.

Nanjo S, Asada K, Yamashita S, Nakajima T, Nakazawa K, Maekita T, Ichinose M, Sugiyama T, Ushijima T.

Gastric Cancer. 2012 Oct;15(4):382-8. doi: 10.1007/s10120-011-0126-1. Epub 2012 Jan 12.

PMID:
22237657
50.

Acalculous cholecystitis in a patient with hepatocellular carcinoma on sorafenib.

Sanda M, Tamai H, Deguchi H, Mori Y, Moribata K, Shingaki N, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M.

ISRN Gastroenterol. 2011;2011:201529. doi: 10.5402/2011/201529. Epub 2010 Nov 23.

Supplemental Content

Loading ...
Support Center